Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial
Publication Type:
Journal Article
Authors:
Dore, Gregory J.;
Altice, Frederick;
Litwin, Alain H.;
Dalgard, Olav;
Gane, Edward J.;
Shibolet, Oren;
Luetkemeyer, Anne;
Nahass, Ronald;
Peng, Cheng-Yuan;
Conway, Brian;
Grebely, Jason;
Howe, Anita Y. M.;
Gendrano, Isaias N.;
Chen, Erluo;
Huang, Hsueh-Cheng;
Dutko, Frank J.;
Nickle, David C.;
Nguyen, Bach-Yen;
Wahl, Janice;
Barr, Eliav;
Robertson, Michael N.;
Platt, Heather L.;
C-EDGE CO-STAR Study GroupSource:
Ann Intern Med, Volume 165, Issue 9, p.625-634 (2016)
Keywords:
Adolescent,
Adult,
Aged,
Antiviral Agents,
Benzofurans,
Buprenorphine,
Buprenorphine, Naloxone Drug Combination,
Double-Blind Method,
Drug Combinations,
Drug Resistance, Viral,
Female,
Genotype,
Hepatitis C, Chronic,
Humans,
Imidazoles,
Male,
Medication Adherence,
Methadone,
Middle Aged,
Opiate Substitution Treatment,
Opioid-Related Disorders,
Quinoxalines,
Recurrence,
Substance Abuse, Intravenous,
Young Adult
